SCHEMBL6430958

SCHEMBL6430958

CN1CCN(c2ccccc2C=C2CCN(c3ccc(Cl)cc3Cl)C2=O)CC1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
BCL2A1 Q16548 2/20 0.47
POLB P06746 1/20 0.44
DRD2 P14416 3/20 0.43
DRD4 P21917 3/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
DRD3 P35462 2/20 0.43
MAPT P10636 3/20 0.42
ALDH1A1 P00352 3/20 0.42
KDM4E B2RXH2 2/20 0.42
HTT P42858 2/20 0.42
HPGD P15428 1/20 0.42
NPY1R P25929 1/20 0.42
NPSR1 Q6W5P4 1/20 0.42
RAD52 P43351 1/20 0.41
L3MBTL1 Q9Y468 2/20 0.41
USP2 O75604 1/20 0.41
MAPK1 P28482 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
LMNA P02545 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6430954 1.00 BCL2A1 (0.47) BCL2A1POLBDRD2DRD4MEN1
SCHEMBL6431240 0.86 MEN1 (0.45) BCL2A1POLBDRD2DRD4MEN1
SCHEMBL6431236 0.86 MEN1 (0.45) BCL2A1POLBDRD2DRD4MEN1
SCHEMBL6434981 0.84 P2RX7 (0.50) BCL2A1POLBMEN1KMT2AMAPT
SCHEMBL6434976 0.84 P2RX7 (0.50) BCL2A1POLBMEN1KMT2AMAPT
SCHEMBL6431435 0.83 BCL2A1 (0.46) BCL2A1DRD2DRD4MEN1KMT2A
SCHEMBL6431436 0.83 BCL2A1 (0.46) BCL2A1DRD2DRD4MEN1KMT2A
SCHEMBL6467373 0.82 KMT2A (0.47) DRD2DRD4MEN1KMT2ADRD3
SCHEMBL6431229 0.81 KMT2A (0.48) BCL2A1POLBDRD2DRD4MEN1
SCHEMBL6431233 0.81 KMT2A (0.48) BCL2A1POLBDRD2DRD4MEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0894085-B1 BENZYL(IDENE)-LACTAM DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE (ANT)AGONISTS OF 5-HT1A- AND/OR 5-HT1D RECEPTORS PFIZER (US) 2005-08-17 EP disclosed
US-6924289-B2 Benzyl(Idene)-lactam derivatives, their preparation and their use as selective (ANT) agonists of 5-HT1A- and/or 5-HT1D receptors PFIZER INC (US) 2005-08-02 US disclosed
US-20030027812-A1 Benzyl(idene)-lactam derivatives, their preperation and their use as selective (ant)agonists of 5-HT1A- and/or 5-HT1D receptors PFIZER INC. 2003-02-06 US disclosed
US-6462048-B2 3-(2-(4-METHYLPIPERAZIN-1-YL)-BENZYLIDENE)-1,3-DIHYDRO-INDOL-2-ONE FOR EXAMPLE; USEFUL AS PSYCHOTHERAPEUTIC AGENTS PFIZER INC. 2002-10-08 US disclosed
US-20020028821-A1 BENZYL(IDENE)-LACTAM DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE (ANT)AGONISTS OF 5-HT1A- AND/OR 5-HT1D RECEPTORS HOWARD HARRY R (US) 2002-03-07 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20020028821-A1 BENZYL(IDENE)-LACTAM DERIVATIVES, THEIR PREPARATION AND THEIR USE AS SELECTIVE (ANT)AGONISTS OF 5-HT1A- AND/OR 5-HT1D RECEPTORS HTR1E, HTR1D, HTR1A BCL2A1 1398/4885POLB 3236/4885DRD2 68/4885
US-20030027812-A1 Benzyl(idene)-lactam derivatives, their preperation and their use as selective (ant)agonists of 5-HT1A- and/or 5-HT1D receptors HTR1A, HTR1E, HTR1D BCL2A1 881/4885POLB 3132/4885DRD2 79/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.